Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine and DAW2020 in Obstructive Sleep Apnea
NCT05350215Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2022
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of DAW2020 in obstructive sleep apnea (OSA), sponsored by Brigham and Women's Hospital. Started Jun 2022; status: recruiting.
02
Drugs
DAW2020
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05350215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05350215.